AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets closed

Allergan plc (AGN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
246.25+0.88 (+0.36%)
At close: 4:01PM EST

246.00 -0.25 (-0.10%)
After hours: 7:06PM EST

People also watch
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close245.37
Open244.00
Bid0.00 x
Ask0.00 x
Day's Range243.48 - 247.08
52 Week Range184.50 - 299.11
Volume2,354,192
Avg. Volume4,081,106
Market Cap92.36B
Beta1.34
PE Ratio (TTM)6.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (1.14%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Drugmakers pledge restraint, but prices will still soar
    Associated Press6 hours ago

    Drugmakers pledge restraint, but prices will still soar

    TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.

  • PR Newswire6 hours ago

    Allergan to Present at Raymond James 38th Annual Institutional Investors Conference

    DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Bill Meury, Allergan's Chief Commercial Officer, will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at www.allergan.com/investors. Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

  • PR Newswire6 hours ago

    Allergan to Present at Cowen and Company 37th Annual Health Care Conference

    DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company, today announced that Allergan Chairman and CEO Brent Saunders will present at the Cowen and Company 37th Annual Health Care Conference in Boston, MA. The presentation will begin at 8:40 a.m. ET on Tuesday, March 7th, 2017 at the Boston Marriott Copley Place. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at www.allergan.com/investors.